Antibody R&D deals abound" /> Antibody R&D deals abound | Chemical & Engineering News
Volume 84 Issue 22 | p. 16 | Concentrates
Issue Date: May 29, 2006

Antibody R&D deals abound

Department: Business

Schering-Plough has teamed up with antibody company Xoma, which will use its phage-display libraries and optimization technologies to discover antibody drugs against targets chosen by Schering-Plough. Xoma will conduct preclinical studies to support regulatory filings and is responsible for cell line and process development, as well as manufacture of antibodies for initial trials. In a separate deal, Icos has licensed Dyax's phage-display library for use in discovery and development of therapeutic . . .

To view the rest of this content, please log in with your ACS ID.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society